NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cx Precision Medicine

Cx Precision Medicine

Private
Fort Worth, TexasHealthcare & Life Scienceshttps://cxprecisionm.com/

Last Round

VC Round

Jun 26, 2024

Total Funding Raised

$3.88M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Cx Precision Medicine is a biotechnology company that develops AI-driven, blood-based diagnostic tests to rule out neurodegenerative disorders such as Alzheimer's and Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

blood-based biomarkerAlzheimer's diagnosticprecision medicineproteomicsclinical decision supportmedical AIneurodegenerative diseaseAI diagnosticsbiotechliquid biopsydiagnostic testhealthcare analyticstriage toolcompanion diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cx Precision Medicine Comparables

Compare Cx Precision Medicine with similar companies based on industry and business-model similarity.

Cx Precision Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
C2N Diagnostics
77%
eNLife Research Private Limited
75%
Point6 Bio
74%

Cx Precision Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 26, 2024
SeedDec 12, 2022
SeedAug 10, 2021
SeedAug 19, 2020
SeedJul 27, 2016

Key People

Founding team and executive leadership

Danguole Altman

President And CEO

Executive Team

Darlene Boudreaux

Chief Financial Officer

Executive Team

FBPharmacolS Heather Giles

Chief Operating Officer

Executive Team

Cx Precision Medicine Investors

Notable investors and investment history

Cx Precision Medicine investors
InvestorRounds
TechFWSeed
HSC NextSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 63% MoM, reaching 1.5K.

  • May 13, 2026

    Monthly visitors grew 2958% MoM, from 31 to 948.

Cx Precision Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cx Precision Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cx Precision Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersFort Worth, Texas
Employee Range6
Year Founded2016
Last FundingJun 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.